ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: TH-PO272

Left Ventricular Global Longitudinal Strain in Stable Stage 5 CKD Patients with Preserved Ejection Fraction Predicts Cardiovascular Events and Mortality After Dialysis Commencement

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis


  • Yu, Chih-Hen, National Cheng Kung University College of Medicine, Tainan, Taiwan
  • Wenhuang, Li, National Cheng Kung University College of Medicine, Tainan, Taiwan
  • Liu, Yen-wen, National Cheng Kung University College of Medicine, Tainan, Taiwan
  • Sung, Junne-Ming, National Cheng Kung University College of Medicine, Tainan, Taiwan

Early detection of subclinical cardiac dysfunction offers opportunity of timely intervention, especially before vulnerable transition from advanced CKD to ESKD. We previously found absolute left ventricular global longitudinal strain (GLS) <15% is predictive to mortality in dialysis patients with preserved ejection fraction (EF), while it's still inconclusive whether the systolic function evaluated by GLS before hemodialysis commencement (HDC) is applicable to predict post-dialysis outcome in clincial stable CKD5 patients.


In this longitudinal prospective observation across HDC, we aimed to predict the post-dialysis cardiovascular outcome with pre-dialysis GLS. The CKD5 patients who had long-term HDC before 2020 were enrolled to post-dialysis outcome follow-up. Inclusions were EF>50% and eligible GLS within 2 years before HDC; main exclusion was frequent admission. The primary outcomes were post-dialysis major adverse cardiovascular cerebral events(MACCE), and secondary outcome was all-cause mortality(ACM).


201 among 242 stable CKD5 patients reached HDC, and 108 with eligible GLS were enrolled. Median duration from examination to HDC was 5.39 months. Median follow-up was 1458 days. GLS<15% is independent predictor of MACCE (HR 2.34[1.11-4.91]p=.025*) and ACM(HR 2.97[1.18-7.49]p=.021*). GLS as continuous variable is independent predictor of MACCE(HR 0.90[0.82-1.00]p=.040*) and ACM(HR 0.84[0.73-0.95]p=.007**). The incremental diagnostic values contributed from GLS<15%(p=.025*) or GLS(p=.042*) were significant in nested Cox models but LVEF (Figure).


LV subclinical systolic dysfunction, assessed by GLS<15% within previous 2 years before HDC, predictedpost-dialysis MACCE and ACM in clinically stable patients having their HDC.

GLS and GLS<15% increase predicting value of Cox models of MACCE; colums represent chi-square value in -2 log likelihood test